Triax Pharmaceuticals

NEW Locoid Lotion
(hydrocortisone butyrate 0.1%)

Launch at the Summer American Academy of Dermatology (AAD) at booths #1715 & 1717

Triax Pharmaceuticals, the marketers of Locoid Lipocream® (hydrocortisone butyrate 0.1%) the leading midpotency
corticosteroids Brand, introduces NEW LOCOID^® LOTION (hydrocortisone butyrate 0.1%) a lotion
vehicle to cover larger areas and hairy areas of affected skin with an elegant, non-greasy application to treat
mild-to-moderate atopic dermatitis in patients as young as 3 months of age². Locoid Lotion and Locoid
Lipocream have been formulated with high concentration of barrier-enhancing lipids. This unique feature
provides skin barrier restorative properties for a wide range of patients.

LOCOID LOTION (hydrocortisone butyrate 0.1% lotion) is the ONLY class 5 corticosteroid indicated for
patients with AD ages 3 months of age and older. It has been proven to provide significant relief of all AD
symptoms in pediatric and adult patients^{2, 3}. By the conclusion of the study, 89% of patients had symptoms of
skin-barrier disruption eliminated or reduced to mild. By Day 8, average pruritis-symptom scores were
reduced to less than mild.

Read the Press Release

Locoid Lipocream
(hydrocortisone butyrate 0.1%) Cream
For Effective Flare Control With Elegance

Hydrolipid Technology Delivers Efficacy for Atopic Skin — 70% lipid content

• Higher lipid content helps restore a healthy skin barrier
• Provides occlusive and emollient properties
• Reduces atopic dermatitis flares
  • Proven effective in clinical trials
  • The #1 branded, mid-potency corticosteroid cream*

Hydrolipid Technology Enhances Elegance — 30% outer phase of water

• Creates a creamy non-greasy feel
• Promotes excellent spreadability
• Fragrance free

Contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. Prolonged use may produce reversible HPA suppression. May cause local adverse reactions, including burning, itching, irritation, and dryness.

FOR SAMPLES CALL: 1-866-733-3639

Locoid Lipocream is a registered trademark of Astellas Pharma Europe B.V. licensed to Triax Pharmaceuticals, LLC.

Available by prescription only

Click here for full prescribing information

Locoid
(hydrocortisone butyrate 0.1%)

The Locoid family of formulations offers a mid-potency, non-halogenated, topical cortico-steroid for relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as eczema and psoriasis.

Locoid contains hydrocortisone butyrate 0.1% in 3 therapeutic vehicles:

Locoid Cream is particularly suitable for acute, weeping, and eudative conditions.

Locoid Ointment is especially suitable for the treatment of dry, often chronic, skin conditions.

Locoid Solution is useful in the treatment of seborrheic dermatitis and eczema occurring in hairy areas of the body.

Available by prescription only

Full product information click:

Locoid Cream
Locoid Ointment
Locoid Solution

Locoid Lipocream is a registered trademark of Astellas Pharma Europe B.V. licensed to
Triax Pharmaceuticals, LLC.

Introducing Tretin-X (tretinoin)

The only Rx retinoid corresponding with the treatment protocol

A simple approach to acne treatment

T³ Foaming Cleanser
A mild, non-irritating, non-stripping, non-soap formulation that leaves the skin feeling soft and clean without drying or tightening

Tretin-X
The efficacy of tretinoin cream or gel in a variety of strengths

T³ Soothing Moisturizer
A light, non-greasy, hydrating moisturizer featuring the soothing complex of aloe vera, dipeptide-l, and bisabolol

To learn more about Tretin-X, visit www.tretinx.com

Tretin-X creams and gels are effective and well tolerated for the topical treatment of acne vulgaris. Use of a mild, non-medicated soap and moisturizer is recommended as part of the overall treatment regimen. Click here to view full prescribing information for Tretin-X.

Minocin

As adjunctive therapy in the treatment of severe acne ...

the power to calm —

the power to clear

One Prescription.
Two Powerful Effects...

• The power to calm inflammatory acne
• Both laboratory and clinical studies document the anti-inflammatory effects of minocycline¹
• The power to eradicate P acnes²

Plus a complimentary set of three calming cosmetic components to complete the dual approach.

T³ CAMLING WIPES — A soothing, alcohol-free wipe that helps remove excess oil-contains sodium hyaluronate, a well-known moisturizing agent

T³ CALMING SERUM — A unique serum featuring sodium hyaluronate, green tea extract, silymarin, and bisabolol-calms skin and restores moisture

T³ CALMING MASQUE — a soothing, calming masque incorporating algae and green tea extracts

To learn more about MINOCIN (Minocycline HCl) Professional Acne Care (PAC), visit www.minocinpac.com

Important Information
The most common adverse events associated with MINOCIN are nausea, vomiting, and diarrhea. Central nervous system adverse events including light-headedness, dizziness, or vertigo have been reported with minocylcine therapy but are generally transient in nature. Other adverse events include tinnitus, headache, sedation, and skin pigmentation, particularly on the face and mucous membranes. MINOCIN is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines or to any of the components of the product formulation.
Click here to view full prescribing information for Minocin.

References:

1. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54(2):259-265.
2. Leyden JJ, McGinley KJ, Kligman AM: Tetracycline and minocycline treatment. Arch Dermatol. 1982;118:19-22.

Triax Patient Assistance Program

Triax Pharmaceuticals, LLC is committed to making our medications available to all patients in need. Our Patient Assistance Program helps provide our products to patients with limited income that are in need of a Triax product.

For more information please contact the Triax Pharmaceuticals Cares Program
at (800) 956-0697 or email:
triaxpharma@rxhope.com

Or click here to access the program on the web.